|
Age group
|
Without loxoscelisma (n = 30)
|
With loxoscelisma
|
|---|
|
Cutaneousb (n = 6)
|
Systemicb (n = 4)
|
|---|
|
Male
|
Female
|
Male
|
Female
|
Male
|
Female
|
|---|
|
18–29
|
11/36.7%
|
16/53.3%
|
1/16.7%
|
2/33.3%
|
2/50%
|
1/25%
|
|
30–60
|
3/10%
|
–
|
2/33.3%
|
1/16.7%
|
–
|
1/25%
|
- aSamples of serum obtained under informed consent (procedure approved by the Research Ethics Committee of the Universidad de Antofagasta – CEIC-UA)
- bAccording to clinical history and/or direct observation of dermonecrotic lesion. Samples are represented as number and percentage (n/%)
